Management of puerperal inferior vena cava thrombosis after massive hemorrhage due to placenta increta


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. The significance of a clinical case of life-threatening complications of true ingrowth of placenta previa, such as massive hemorrhage and inferior vena cava thrombosis with a high risk for pulmonary embolism, is determined by the geometric increase in the incidence of abnormally invasive placenta and by the association of near-miss cases with the latter, which dictates the systematization of practical knowledge, the evaluation of the effectiveness of various options for obstetric tactics, and the elaboration of an interdisciplinary approach. Clinical case report. In the absence of antenatal diagnosis of placental ingrowth, complications, such as hemorrhage and thrombosis of the inferior vena cava, cannot be prevented in obstetric facilities of different medical care levels during staged treatment. The provision of care to the patient by the physicians of an emergency and planned counseling team and a pediatric neonatology team of the regional perinatal center in the central district hospital, followed by specialized treatment determined a favorable outcome for both the mother and the newborn. A separate analysis of complicating factors occurring in the management of pregnant and puerperal women with vital complications of placental ingrowth updates the issues of early diagnosis, optimal delivery tactics, preoperative readiness of a multidisciplinary team, and timely prevention of thromboembolic events. Conclusion. The accumulation of clinical experience and the elaboration of high-evidence-based treatment policy will undoubtedly make it possible to avoid critical conditions and to substantiate an organ-sparing approach as a determining one.

Texto integral

Acesso é fechado

Sobre autores

Tatyana Tezikova

V.D. Seredavin Samara Regional Clinical Hospital

Email: t-tezikova@mail.ru
Deputy chief doctor

Marina Nechaeva

V.D. Seredavin Samara Regional Clinical Hospital

Email: nechaevamv@sokb.ru
Ph.D., Head of reception

Yuri Tezikov

Samara State Medical University, Ministry of Health of Russia

Email: yra.75@inbox.ru
Professor, Doctor of medical Sciences, Head of the Department

Igor Lipatov

Samara State Medical University, Ministry of Health of Russia

Email: I.lipatoff20l2@yandex.ru
Professor, Doctor of medical Sciences, Department

Tatyana Belokoneva

Samara State Medical University, Ministry of Health of Russia

Email: belokonevats@mail.ru
Ph.D., associate professor of the Department

Roman Shmakov

Academiciaan. V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
MD, PhD, professor, director of the institute of Оbstetrics

Bibliografia

  1. Say L., Chou D., Gemmill A., Tungalp 0., Moller A.B., Daniels J., Gtilmezoglu A.M., Temmerman M., Alkema L. Global causes of maternal death: A WHO systematic analysis. Lancet Glob. Heal. 2014.2(6): 323-333.
  2. O’Brien J.M., Barton J.R., Donaldson E.S. The management of placenta percreta: Conservative and operative strategies. Am. J. Obstet. Gynecol. 1996. 175(6): 1632-8.
  3. Matsubara S., Kuwata T., Usui R., Watanabe T., Izumi A., Ohkuchi A., Suzuki M., Nakata M. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accrete. Acta Obstet. Gynecol. Scand. 2013. 92 (4): 372-7.
  4. Chou M.M., Ke Y.M., Wu H.C., Tsai C.P., Ho E.S., Ismail H., Palacios Jaraquemada J.M. Temporary Cross-clamping of the Infrarenal Abdominal Aorta During Cesarean Hysterectomy to Control Operative Blood Loss in Placenta Previa Increta/Percreta. Taiwan. J. Obstet. Gynecol. 2010; 49(1): 72-76.
  5. Wong V.V., Burke G. Planned conservative management of placenta percreta. J. Obstet. Gynaecol. 2012; 32(5): 447-452. doi: 10.3109/01443615.2012.669429.
  6. Khan M., Sachdeva P., Arora R., Bhasin S. Conservative management of morbidly adherent placenta - A case report and review of literature. Placenta. 2013; 34(10): 963-966.
  7. Simsek T., Saruhan Z., Karaveli S. Placenta percreta: Conservative treatment -segmental uterine resection with placenta in one piece. J. Obstet. Gynaecol. 2010; 30(7): 735-736. doi: 10.3109/01443615.2010.501918
  8. Chandraharan E., Rao S., Belli A.M., Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int. J. Gynecol. Obstet. 2012; 117(2): 191-194.
  9. Баринов С.В. и др. Опыт применения вагинального и маточного катетеров Жуковского, местного гемостатика при лечении послеродовых кровотечений во время кесарева сечения. Акушерство и гинекология. 2016; 7: 34-40. https://dx.doi.org/10.18565/aig.2016.7.34-40
  10. Bajwa S.K., Singh A., Bajwa S.J. Contemporary issues in the management of abnormal placentation during pregnancy in developing nations: An Indian perspective. Int. J. Crit.Illn.Inj.Sci. 2013; 3: 183-9.
  11. Hudon L., Belfort M. A., Broome D. R. Diagnosis and management of placenta percreta: a review. Obstet. Gynecol. Surv. 1998; 53(8): 509-517.
  12. Eller A.G., Bennett M.A., Sharshiner M., Masheter C., Soisson A.P., Dodson M., Silver R.M. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet. Gynecol. 2011; 117(2 Pt1): 331-337.
  13. Wright J.D., Pri-Paz S., Herzog T.J., Shah M., Bonanno C., Lew in S.N., Simpson L.L., Gaddipati S., Sun X., D’Alton M.E., Devine P. Predictors of massive blood loss in women with placenta accrete. Am. J. Obstet. Gynecol. 2011; 205(1): 38.e1-6.
  14. Виницкий А.А., Шмаков Р.Г., Чупрынин В.Д. Сравнительная оценка эффективности методов хирургического гемостаза при органосохраняющем родоразрешении у пациенток с врастанием плаценты. Акушерство и гинекология. 2017; 7: 68-74.
  15. Федорова Т.А., Шмаков Р.Г., Пырегов А.В., Виницкий А.А. Опыт применения рекомбинантного активированного фактора коагуляции VII в лечении массивного акушерского кровотечения при врастании плаценты. Медицинский совет. 2016; 12: 14-18. https://doi. org/10.21518/2079-701X-2016-12-14-20
  16. Alalaf S.K., Jawad R.K., Muhammad P.R. et al. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy Childbirth.2015 Mar 28; 15: 72. doi: 10.1186/ s12884-015-0515-2. PubMed PMID: 25884460
  17. James A.H., Tapson V.F., Goldhaber S.Z. Thrombosis during pregnancy and the postpartum period. American Journal of Obstetrics and Gynecology. 2005; 193 (1): 216-19.
  18. Dizon-Townson D.S., Nelson L.M., Jang H., Varner M.W., Ward K. The incidence of the factor V. Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J. Obstet Gynecol. 1997; 176:883-6.doi: 10.1016/ S0002-9378(97)70615-X

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2019